Totally no ragistration and no payment side for dating with online girls in webcam Updating a meta analysis of intervention research with challenging behaviour

JAMAJAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Facial Plastic Surgery JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Evidence reviews for the US Preventive Services Task Force (USPSTF) use an analytic framework to visually display the key questions that the review will address to allow the USPSTF to evaluate the effectiveness and safety of a preventive service. doi:10.1017/S1368980008002802Pub Med Google Scholar Crossref Jackson CL, Wang NY, Yeh HC, Szklo M, Dray-Spira R, Brancati FL. The questions are depicted by linkages that relate interventions and outcomes. doi:10.1016/j.amepre.20Pub Med Google Scholar Crossref Kruseman M, Schmutz N, Carrard I. doi:10.1159/000478096Pub Med Google Scholar Crossref Vieira PN, Silva MN, Mata J, et al. doi:10.1007/s10865-012-9454-9Pub Med Google Scholar Crossref Feller S, Müller A, Mayr A, Engeli S, Hilbert A, de Zwaan M. doi:10.1002/oby.21054Pub Med Google Scholar Crossref Der Sarkissian M, Bhak RH, Huang J, et al. doi:10.1080/03007995.2017.1307173Pub Med Google Scholar Crossref Abell JE, Egan BM, Wilson PW, Lipsitz S, Woolson RF, Lackland DT. doi:10.1177/003335490712200412Pub Med Google Scholar Crossref Abell JE, Egan BM, Wilson PW, Lipsitz S, Woolson RF, Lackland DT. doi:10.2105/AJPH.2006.093781Pub Med Google Scholar Crossref Ni Mhurchu C, Rodgers A, Pan WH, Gu DF, Woodward M; Asia Pacific Cohort Studies Collaboration. doi:10.1093/ije/dyh163Pub Med Google Scholar Crossref Huxley R, Barzi F, Lee CM, et al; Obesity in Asia Collaboration. doi:10.2337/dc07-1455Pub Med Google Scholar Crossref Razak F, Anand S, Vuksan V, et al; SHARE Investigators. doi:10.1038/0802937Pub Med Google Scholar Crossref Sánchez-Castillo CP, Velázquez-Monroy O, Berber A, Lara-Esqueda A, Tapia-Conyer R, James WP; Encuesta Nacional de Salud (ENSA) 2000 Working Group. doi:10.1038/oby.2003.60Pub Med Google Scholar Crossref Stevens J, Juhaeri, Cai J, Jones DW. doi:10.1093/ajcn/75.6.986Pub Med Google Scholar Crossref Stommel M, Schoenborn CA. doi:10.1038/oby.2009.472Pub Med Google Scholar Crossref WHO Expert Consultation. doi:10.1016/S0140-6736(03)15268-3Pub Med Google Scholar Crossref Wen CP, David Cheng TY, Tsai SP, et al.

Risk of Losing ≥5% of Body Weight in Medication-Based Weight Loss Interventions Compared With Controls, All Studies and All Timepoints (Key Question 2)e References National Center for Health Statistics. Bogers RP, Bemelmans WJ, Hoogenveen RT, et al; BMI-CHD Collaboration Investigators. doi:10.1001/archinte.1Pub Med Google Scholar Crossref Colditz GA, Willett WC, Rotnitzky A, Manson JE. doi:10.7326/0003-4819-122-7-199504010-00001Pub Med Google Scholar Crossref Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, Anis AH. doi:10.1186/1471-2458-9-88Pub Med Google Scholar Crossref Bhaskaran K, Douglas I, Forbes H, dos-Santos-Silva I, Leon DA, Smeeth L. doi:10.1016/S0140-6736(14)60892-8Pub Med Google Scholar Crossref Afshin A, Forouzanfar MH, Reitsma MB, et al; GBD 2015 Obesity Collaborators. doi:10.1056/NEJMoa1614362Pub Med Google Scholar Crossref Smith AW, Borowski LA, Liu B, et al. Health, United States, Report 2016: With Chartbook on Long-term Trends in Health. Association of overweight with increased risk of coronary heart disease partly independent of blood pressure and cholesterol levels: a meta-analysis of 21 cohort studies including more than 300 000 persons. Weight gain as a risk factor for clinical diabetes mellitus in women. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5·24 million UK adults. Health effects of overweight and obesity in 195 countries over 25 years. Reasons for exclusion: Aim: Study aim was not relevant. Intentional weight loss and incidence of obesity-related cancers: the Iowa Women’s Health Study. Weight loss and coronary heart disease: sensitivity analysis for unmeasured confounding by undiagnosed disease. Attribution of causes of weight loss and weight gain to 3-year mortality in older adults: results from the Longitudinal Aging Study Amsterdam. Prospective study of intentionality of weight loss and mortality in older women: the Iowa Women’s Health Study. Prospective study of intentional weight loss and mortality in overweight white men aged 40-64 years. Intention to lose weight, weight changes, and 18-y mortality in overweight individuals without co-morbidities. Voluntary and involuntary weight loss: associations with long term mortality in 9,228 middle-aged and elderly men. Surgical vs medical treatments for type 2 diabetes mellitus: a randomized clinical trial. The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003-2012. The impact of bariatric surgery on obstructive sleep apnea: a systematic review. Changes in quality of life and body image after gastric bypass surgery. Mental health conditions among patients seeking and undergoing bariatric surgery: a meta-analysis. Change in pain and physical function following bariatric surgery for severe obesity. Role of the gut on glucose homeostasis: lesson learned from metabolic surgery. Setting: Study was not conducted in a country relevant to United States practice or not conducted in, recruited from, or feasible for primary care or a health system. doi:10.1038/oby.2011.329Pub Med Google Scholar Crossref Rodriguez-Cristobal JJ, Alonso-Villaverde C, Panisello JM, et al. doi:10.1186/s12875-017-0644-y Pub Med Google Scholar Crossref Phelan S, Hagobian T, Brannen A, et al. doi:10.1001/jama.2017.7119Pub Med Google Scholar Crossref Trials of Hypertension Prevention Collaborative Research Group. doi:10.1001/jama.1992.03480090061028Pub Med Google Scholar Crossref Uusitupa M, Peltonen M, Lindström J, et al; Finnish Diabetes Prevention Study Group. doi:10.1371/0005656Pub Med Google Scholar Crossref Shea MK, Nicklas BJ, Houston DK, et al. doi:10.3945/ajcn.110.006379Pub Med Google Scholar Crossref Ratner R, Goldberg R, Haffner S, et al; Diabetes Prevention Program Research Group. doi:10.2337/diacare.28.4.888Pub Med Google Scholar Crossref Rubin RR, Peyrot M, Wang NY, et al. doi:10.1007/s11136-013-0363-3Pub Med Google Scholar Crossref Florez H, Pan Q, Ackermann RT, et al; Diabetes Prevention Program Research Group. doi:10.1007/s11606-012-2122-5Pub Med Google Scholar Crossref Ackermann RT, Edelstein SL, Narayan KM, et al; Diabetes Prevention Program Research Group. doi:10.1038/oby.2009.114Pub Med Google Scholar Crossref Demark-Wahnefried W, Colditz GA, Rock CL, et al; ENERGY Trial Group. doi:10.1007/s10549-015-3627-5Pub Med Google Scholar Crossref Mc Carroll ML, Armbruster S, Frasure HE, et al. doi:10.1016/j.ygyno.20Pub Med Google Scholar Crossref Sarwer DB, Moore RH, Diewald LK, et al; POWER-UP Research Group. doi:10.1038/ijo.2013.93Pub Med Google Scholar Crossref Swencionis C, Wylie-Rosett J, Lent MR, et al. doi:10.1037/a0029186Pub Med Google Scholar Crossref Lindström J, Peltonen M, Eriksson JG, et al; Finnish Diabetes Prevention Study (DPS). doi:10.1007/s00125-012-2752-5Pub Med Google Scholar Crossrefle Roux CW, Astrup A, Fujioka K, et al; SCALE Obesity Prediabetes NN8022-1839 Study Group. doi:10.1016/S0140-6736(17)30069-7Pub Med Google Scholar Crossref Williamson DF, Pamuk E, Thun M, Flanders D, Byers T, Heath C. doi:10.1093/a117386Pub Med Google Scholar Crossref Wannamethee SG, Shaper AG, Walker M. doi:10.1136/jech.2003.015651Pub Med Google Scholar Crossref Gregg EW, Gerzoff RB, Thompson TJ, Williamson DF. Population inclusion criteria: Study was not conducted in an included population. doi:10.1016/S0140-6736(10)60888-4Pub Med Google Scholar Crossref Haapala I, Barengo NC, Biggs S, Surakka L, Manninen P. doi:10.1017/S1368980009005230Pub Med Google Scholar Crossref Hauptman J, Lucas C, Boldrin MN, Collins H, Segal KR. doi:10.1001/archfami.9.2.160Pub Med Google Scholar Crossref Hill JO, Hauptman J, Anderson JW, et al. doi:10.1093/ajcn/69.6.1108Pub Med Google Scholar Crossref Hunt K, Wyke S, Gray CM, et al. doi:10.1016/S0140-6736(13)62420-4Pub Med Google Scholar Crossref Huseinovic E, Bertz F, Leu Agelii M, Hellebö Johansson E, Winkvist A, Brekke HK. doi:10.3945/ajcn.116.135673Pub Med Google Scholar Crossref Jakicic JM, Otto AD, Lang W, et al. doi:10.1038/oby.2010.122Pub Med Google Scholar Crossref Jansson SP, Engfeldt P, Magnuson A, Pt GL, Liljegren G. doi:10.1186/1756-0500-6-213Pub Med Google Scholar Crossref Jebb SA, Ahern AL, Olson AD, et al. doi:10.1016/S0140-6736(11)61344-5Pub Med Google Scholar Crossref Jeffery RW, Wing RR, Thorson C, et al. doi:10.1037/0022-006X.61.6.1038Pub Med Google Scholar Crossref Jolly K, Lewis A, Beach J, et al. doi:10.1136/bmj.d6500Pub Med Google Scholar Crossref Jones DW, Miller ME, Wofford MR, et al. doi:10.1016/S0895-7061(99)00123-5Pub Med Google Scholar Crossref Kanke S, Kawai T, Takasawa N, Mashiyama Y, Ishii A, Kassai R. doi:10.1186/s12930-015-0022-7Pub Med Google Scholar Crossref Katula JA, Vitolins MZ, Rosenberger EL, et al. Benefits of liraglutide treatment in overweight and obese older individuals with prediabetes. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. Weight reduction and long-term maintenance after 18 months treatment with orlistat for obesity. The Women on the Move Through Activity and Nutrition (WOMAN) study: final 48-month results. Prevention of diabetes self-management program (PREDIAS): effects on weight, metabolic risk factors, and behavioral outcomes. The effect of orlistat on body weight and coronary heart disease risk profile in obese patients: the Swedish Multimorbidity Study. An internet-based intervention with brief nurse support to manage obesity in primary care (POWe R ): a pragmatic, parallel-group, randomised controlled trial. Weight loss by telemonitoring of nutrition and physical activity in patients with metabolic syndrome for 1 year. Translating the Diabetes Prevention Program lifestyle intervention for weight loss into primary care: a randomized trial. Comparison of commercial and self-initiated weight loss programs in people with prediabetes: a randomized control trial. Lorcaserin, a 5-HT(2C) receptor agonist, reduces body weight by decreasing energy intake without influencing energy expenditure. Weight loss maintenance following a primary care intervention for low-income minority women. Gentle exercise of 40 minutes with dietary counseling is effective in treating metabolic syndrome. Improving management of obesity in primary care: cluster randomised trial. 12-month outcomes and process evaluation of the SHED-IT RCT: an internet-based weight loss program targeting men. The effects of orlistat on weight and on serum lipids in obese patients with hypercholesterolemia: a randomized, double-blind, placebo-controlled, multicentre study. Behavioral change during weight loss program and one-year follow-up: Saku Control Obesity Program (SCOP) in Japan. A pragmatic randomised controlled trial in primary care of the Camden Weight Loss (CAMWEL) programme. A web-based lifestyle intervention for women with recent gestational diabetes mellitus: a randomized controlled trial. Outcomes of a Latino community-based intervention for the prevention of diabetes: the Lawrence Latino Diabetes Prevention Project. Results of a pilot diabetes prevention intervention in East Harlem, New York City: Project HEED. Outcomes of a 12-month web-based intervention for overweight and obese men. Long-term weight maintenance after a 17-week weight loss intervention with or without a one-year maintenance program: a randomized controlled trial. Prevention of type 2 diabetes in adults with impaired glucose tolerance: the European Diabetes Prevention RCT in Newcastle upon Tyne, UK. Effects of four maintenance programs on the long-term management of obesity. A randomized, controlled trial of 3.0 mg of liraglutide in weight management. Lifestyle counseling to reduce body weight and cardiometabolic risk factors among truck and bus drivers—a randomized controlled trial. Effect of orlistat on weight regain and cardiovascular risk factors following a very-low-energy diet in abdominally obese patients: a 3-year randomized, placebo-controlled study. Results of the Exercise and Nutrition to Enhance Recovery and Good Health for You (ENERGY) trial: a behavioral weight loss intervention in overweight or obese breast cancer survivors. Randomized trial of a multifaceted commercial weight loss program. The effectiveness of two community-based weight loss strategies among obese, low-income US Latinos. Trial of prevention and reduction of obesity through active living in clinical settings: a randomized controlled trial. Weight loss, weight maintenance, and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity. Text4Diet: a randomized controlled study using text messaging for weight loss behaviors. Enhancing long-term weight loss maintenance: 2 year results from the Keep It Off randomized controlled trial. Using self-determination theory to promote physical activity and weight control: a randomized controlled trial in women. A feasibility randomised controlled trial of a motivational interviewing–based intervention for weight loss maintenance in adults. Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. Orlistat 60 mg reduces visceral adipose tissue: a 24-week randomized, placebo-controlled, multicenter trial. Multicenter, placebo-controlled trial of lorcaserin for weight management. Efficacy of orlistat 60 mg on weight loss and body fat mass in US Army soldiers. Weight loss intervention in phase 1 of the Trials of Hypertension Prevention. Long-term weight loss and changes in blood pressure: results of the Trials of Hypertension Prevention, Phase II. Cell phone intervention for you (CITY): a randomized, controlled trial of behavioral weight loss intervention for young adults using mobile technology [published correction appears in Obesity (Silver Spring). 2015;39(1):187, 2013;37(11):1514, and 2015;39(1):187].

Population not generalizable or relevant: Included population was not generalizable to a primary care population. doi:10.1016/S0140-6736(11)60205-5Pub Med Google Scholar Crossref Godino JG, Merchant G, Norman GJ, et al. doi:10.1016/S2213-8587(16)30105-XPub Med Google Scholar Crossref Greaves C, Gillison F, Stathi A, et al. doi:10.1186/s12966-014-0159-z Pub Med Google Scholar Crossref Greenway FL, Fujioka K, Plodkowski RA, et al; COR-I Study Group. Weight loss by mobile phone: a 1-year effectiveness study. Orlistat in the long-term treatment of obesity in primary care settings. Orlistat, a lipase inhibitor, for weight maintenance after conventional dieting: a 1-y study. A gender-sensitised weight loss and healthy living programme for overweight and obese men delivered by Scottish Premier League football clubs (FFIT): a pragmatic randomised controlled trial. Effectiveness of a weight loss intervention in postpartum women: results from a randomized controlled trial in primary health care. The effect of physical activity on 18-month weight change in overweight adults. Interventions for lifestyle changes to promote weight reduction, a randomized controlled trial in primary health care. Primary care referral to a commercial provider for weight loss treatment versus standard care: a randomised controlled trial. Strengthening behavioral interventions for weight loss: a randomized trial of food provision and monetary incentives. Comparison of range of commercial or primary care led weight reduction programmes with minimal intervention control for weight loss in obesity: Lighten Up randomised controlled trial. The effect of weight loss intervention on antihypertensive medication requirements in the Hypertension Optimal Treatment (HOT) study. Interventions for body weight reduction in obese patients during short consultations: an open-label randomized controlled trial in the Japanese primary care setting. One-year results of a community-based translation of the Diabetes Prevention Program: Healthy-Living Partnerships to Prevent Diabetes (HELP PD) Project [published correction appears in Diabetes Care.

uses cookies to personalize content, tailor ads and improve the user experience.

By using our site, you agree to our collection of information through the use of cookies.

No relevant outcomes: Study did not have relevant outcomes or had incomplete outcomes. doi:10.1002/oby.21226Pub Med Google Scholar Crossref Svetkey LP, Stevens VJ, Brantley PJ, et al; Weight Loss Maintenance Collaborative Research Group. doi:10.1001/jama.2Pub Med Google Scholar Crossref Swinburn BA, Carey D, Hills AP, et al. doi:10.1111/j.1463-1326.2004.00467.x Pub Med Google Scholar Crossref Torgerson JS, Hauptman J, Boldrin MN, Sjöström L. doi:10.2337/diacare.27.1.155Pub Med Google Scholar Crossref Tsai AG, Wadden TA, Rogers MA, Day SC, Moore RH, Islam BJ. doi:10.1038/oby.2009.457Pub Med Google Scholar Crossref Tuomilehto J, Lindström J, Eriksson JG, et al; Finnish Diabetes Prevention Study Group. doi:10.1056/NEJM200105033441801Pub Med Google Scholar Crossref Van Gaal LF, Broom JI, Enzi G, Toplak H; Orlistat Dose-Ranging Study Group. doi:10.1007/s002280050433Pub Med Google Scholar Crossrefvan Wier MF, Dekkers JC, Hendriksen IJ, et al. doi:10.1097/JOM.0b013e31821f2bbb Pub Med Google Scholar Crossref Voils CI, Olsen MK, Gierisch JM, et al. doi:10.7326/M16-2160Pub Med Google Scholar Crossrefvon Gruenigen V, Frasure H, Kavanagh MB, et al. doi:10.1016/j.ygyno.20Pub Med Google Scholar Crossref Wadden TA, Volger S, Sarwer DB, et al. doi:10.1056/NEJMoa1109220Pub Med Google Scholar Crossref Wadden TA, Foreyt JP, Foster GD, et al. doi:10.1038/oby.2010.147Pub Med Google Scholar Crossref Wadden TA, Hollander P, Klein S, et al; NN8022-1923 Investigators. doi:10.1038/ijo.2013.120Pub Med Google Scholar Crossref Wing RR, Venditti E, Jakicic JM, Polley BA, Lang W. doi:10.2337/diacare.21.3.350Pub Med Google Scholar Crossref Wylie-Rosett J, Swencionis C, Ginsberg M, et al. doi:10.1016/S0002-8223(01)00284-XPub Med Google Scholar Crossref Yeh MC, Heo M, Suchday S, et al. doi:10.1111/dme.12848Pub Med Google Scholar Crossref Young MD, Callister R, Collins CE, Plotnikoff RC, Aguiar EJ, Morgan PJ. doi:10.1002/oby.21696Pub Med Google Scholar Crossref Beeken RJ, Leurent B, Vickerstaff V, et al. doi:10.1038/ijo.2016.206Pub Med Google Scholar Crossref Fischer HH, Fischer IP, Pereira RI, et al. doi:10.2337/dc15-2137Pub Med Google Scholar Crossref Jenkins DJA, Boucher BA, Ashbury FD, et al. doi:10.1016/20Pub Med Google Scholar Crossref O’Brien MJ, Perez A, Scanlan AB, et al. doi:10.1016/j.amepre.20Pub Med Google Scholar Crossref Thomas JG, Raynor HA, Bond DS, et al. doi:10.1002/oby.21846Pub Med Google Scholar Crossref Ahern AL, Wheeler GM, Aveyard P, et al. doi:10.1016/S0140-6736(17)30647-5Pub Med Google Scholar Crossref Logue E, Sutton K, Jarjoura D, Smucker W, Baughman K, Capers C. doi:10.1038/oby.2005.106Pub Med Google Scholar Crossref Mensink M, Corpeleijn E, Feskens EJ, et al. doi:10.1016/S0168-8227(03)00067-6Pub Med Google Scholar Crossref Whelton PK, Appel LJ, Espeland MA, et al; TONE Collaborative Research Group. doi:10.1001/jama.2Pub Med Google Scholar Crossref Nilsen V, Bakke PS, Gallefoss F. doi:10.1186/1471-2458-11-893Pub Med Google Scholar Crossref Kumanyika SK, Fassbender JE, Sarwer DB, et al. study of weight management in primary care practices. Effectiveness of a motivational intervention on overweight/obese patients in the primary healthcare: a cluster randomized trial. Effect of an internet-based program on weight loss for low-income postpartum women: a randomized clinical trial. The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels: results of the Trials of Hypertension Prevention, Phase I. Ten-year mortality and cardiovascular morbidity in the Finnish Diabetes Prevention Study—secondary analysis of the randomized trial. The effect of intentional weight loss on all-cause mortality in older adults: results of a randomized controlled weight-loss trial. Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the Diabetes Prevention Program. Patient-reported outcomes in the practice-based opportunities for weight reduction (POWER) trial. Impact of lifestyle intervention and metformin on health-related quality of life: the Diabetes Prevention Program randomized trial. Changes in health state utilities with changes in body mass in the Diabetes Prevention Program. Quality of life outcomes from the Exercise and Nutrition Enhance Recovery and Good Health for You (ENERGY) randomized weight loss trial among breast cancer survivors. Self-efficacy, quality of life, and weight loss in overweight/obese endometrial cancer survivors (SUCCEED): a randomized controlled trial. The impact of a primary care-based weight loss intervention on the quality of life. Weight change, psychological well-being, and vitality in adults participating in a cognitive-behavioral weight loss program. Improved lifestyle and decreased diabetes risk over 13 years: long-term follow-up of the randomised Finnish Diabetes Prevention Study (DPS). 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial. Prospective study of intentional weight loss and mortality in never-smoking overweight US white women aged 40-64 years. Overweight and obesity and weight change in middle aged men: impact on cardiovascular disease and diabetes. Intentional weight loss and death in overweight and obese U.

Reporting of outcomes: Outcomes not presented in a way that could be abstracted for the review. doi:10.2337/dc10-2115Pub Med Google Scholar Crossref Kim SH, Abbasi F, Lamendola C, et al. doi:10.2337/dc13-0354Pub Med Google Scholar Crossref Knowler WC, Barrett-Connor E, Fowler SE, et al; Diabetes Prevention Program Research Group. doi:10.1056/NEJMoa012512Pub Med Google Scholar Crossref Krempf M, Louvet JP, Allanic H, Miloradovich T, Joubert JM, Attali JR. doi:10.1038/0802281Pub Med Google Scholar Crossref Kuller LH, Pettee Gabriel KK, Kinzel LS, et al. doi:10.1038/oby.2011.80Pub Med Google Scholar Crossref Kulzer B, Hermanns N, Gorges D, Schwarz P, Haak T. doi:10.2337/dc08-2141Pub Med Google Scholar Crossref Lindgärde F. doi:10.1046/j.1365-2796.2000.00720.x Pub Med Google Scholar Crossref Little P, Stuart B, Hobbs FR, et al. doi:10.1016/S2213-8587(16)30099-7Pub Med Google Scholar Crossref Luley C, Blaik A, Götz A, et al. doi:10.1080/07315724.2013.875437Pub Med Google Scholar Crossref Ma J, Yank V, Xiao L, et al. doi:10.1001/2013.jamainternmed.987Pub Med Google Scholar Crossref Marrero DG, Palmer KN, Phillips EO, Miller-Kovach K, Foster GD, Saha CK. doi:10.2105/AJPH.2015.303035Pub Med Google Scholar Crossref Martin CK, Redman LM, Zhang J, et al. doi:10.1210/jc.2010-1848Pub Med Google Scholar Crossref Martin PD, Dutton GR, Rhode PC, Horswell RL, Ryan DH, Brantley PJ. doi:10.1038/oby.2008.399Pub Med Google Scholar Crossref Mitsui T, Shimaoka K, Tsuzuku S, Kajioka T, Sakakibara H. doi:10.1620/tjem.215.355Pub Med Google Scholar Crossref Moore H, Summerbell CD, Greenwood DC, et al. doi:10.1136/bmj.327.7423.1085Pub Med Google Scholar Crossref Morgan PJ, Lubans DR, Collins CE, Warren JM, Callister R. doi:10.1038/oby.2010.119Pub Med Google Scholar Crossref Muls E, Kolanowski J, Scheen A, Van Gaal L; Obel Hyx Study Group. doi:10.1038/0801814Pub Med Google Scholar Crossref Nakade M, Aiba N, Suda N, et al; SCOP Group. Pub Med Google Scholar Nanchahal K, Power T, Holdsworth E, et al. doi:10.1136/bmjopen-2011-000793Pub Med Google Scholar Crossref Nicklas JM, Zera CA, England LJ, et al. doi:10.1097/AOG.0000000000000420Pub Med Google Scholar Crossref Ockene IS, Tellez TL, Rosal MC, et al. doi:10.2105/AJPH.2011.300357Pub Med Google Scholar Crossref Parikh P, Simon EP, Fei K, Looker H, Goytia C, Horowitz CR. doi:10.2105/AJPH.2009.170910Pub Med Google Scholar Crossref Patrick K, Calfas KJ, Norman GJ, et al. doi:10.1007/s12160-011-9296-7Pub Med Google Scholar Crossref Pekkarinen T, Kaukua J, Mustajoki P. doi:10.1155/2015/651460Pub Med Google Scholar Crossref Penn L, White M, Oldroyd J, Walker M, Alberti KG, Mathers JC. doi:10.1186/1471-2458-9-342Pub Med Google Scholar Crossref Perri MG, Mc Allister DA, Gange JJ, Jordan RC, Mc Adoo G, Nezu AM. doi:10.1037/0022-006X.56.4.529Pub Med Google Scholar Crossref Pi-Sunyer X, Astrup A, Fujioka K, et al; SCALE Obesity and Prediabetes NN8022-1839 Study Group. doi:10.1056/NEJMoa1411892Pub Med Google Scholar Crossref Puhkala J, Kukkonen-Harjula K, Mansikkamäki K, et al. doi:10.5271/sjweh.3463Pub Med Google Scholar Crossref Richelsen B, Tonstad S, Rössner S, et al. doi:10.2337/dc06-0210Pub Med Google Scholar Crossref Rock CL, Flatt SW, Byers TE, et al. doi:10.1200/JCO.20Pub Med Google Scholar Crossref Rock CL, Pakiz B, Flatt SW, Quintana EL. doi:10.1038/oby.2007.614Pub Med Google Scholar Crossref Rosas LG, Thiyagarajan S, Goldstein BA, et al. doi:10.1016/20Pub Med Google Scholar Crossref Ross R, Lam M, Blair SN, et al. doi:10.1001/archinternmed.2011.1972Pub Med Google Scholar Crossref Rössner S, Sjöström L, Noack R, Meinders AE, Noseda G; European Orlistat Obesity Study Group. doi:10.1038/oby.2000.8Pub Med Google Scholar Crossref Shapiro JR, Koro T, Doran N, et al. doi:10.1016/j.ypmed.20Pub Med Google Scholar Crossref Sherwood NE, Crain AL, Martinson BC, et al. doi:10.1016/j.ypmed.20Pub Med Google Scholar Crossref Silva MN, Vieira PN, Coutinho SR, et al. doi:10.1007/s10865-009-9239-y Pub Med Google Scholar Crossref Simpson SA, Mc Namara R, Shaw C, et al. doi:10.3310/hta19500Pub Med Google Scholar Crossref Sjöström L, Rissanen A, Andersen T, et al; European Multicentre Orlistat Study Group. doi:10.1016/S0140-6736(97)11509-4Pub Med Google Scholar Crossref Smith SR, Stenlof KS, Greenway FL, et al. doi:10.1038/oby.2011.143Pub Med Google Scholar Crossref Smith SR, Weissman NJ, Anderson CM, et al; Behavioral Modification and Lorcaserin for Overweight and Obesity Management (BLOOM) Study Group. doi:10.1056/NEJMoa0909809Pub Med Google Scholar Crossref Smith TJ, Crombie A, Sanders LF, et al. doi:10.1016/20Pub Med Google Scholar Crossref Stevens VJ, Corrigan SA, Obarzanek E, et al; TOHP Collaborative Research Group. doi:10.1001/archinte.1993.00410070039006Pub Med Google Scholar Crossref Stevens VJ, Obarzanek E, Cook NR, et al; Trials for the Hypertension Prevention Research Group. doi:10.7326/0003-4819-134-1-200101020-00007Pub Med Google Scholar Crossref Svetkey LP, Batch BC, Lin PH, et al. Comparison of strategies for sustaining weight loss: the weight loss maintenance randomized controlled trial. Effect of orlistat on cardiovascular disease risk in obese adults. XENical in the prevention of Diabetes in Obese Subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. A primary care intervention for weight loss: results of a randomized controlled pilot study. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. Efficacy and tolerability of orlistat in the treatment of obesity: a 6-month dose-ranging study. Effectiveness of phone and e-mail lifestyle counseling for long term weight control among overweight employees. Maintenance of weight loss after initiation of nutrition training: a randomized trial. Survivors of uterine cancer empowered by exercise and healthy diet (SUCCEED): a randomized controlled trial. A two-year randomized trial of obesity treatment in primary care practice. Weight loss with naltrexone SR/bupropion SR combination therapy as an adjunct to behavior modification: the COR-BMOD trial. Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: the SCALE Maintenance randomized study [published corrections appear in Int J Obes (Lond). Lifestyle intervention in overweight individuals with a family history of diabetes. Computerized weight loss intervention optimizes staff time: the clinical and cost results of a controlled clinical trial conducted in a managed care setting. Translation of the Diabetes Prevention Program for diabetes risk reduction in Chinese immigrants in New York City. Efficacy of a gender-tailored intervention to prevent weight regain in men over 3 years: a weight loss maintenance RCT. A brief intervention for weight control based on habit-formation theory delivered through primary care: results from a randomised controlled trial. Text message support for weight loss in patients with prediabetes: a randomized clinical trial. Effect of current dietary recommendations on weight loss and cardiovascular risk factors. PREVENT-DM comparative effectiveness trial of lifestyle intervention and metformin. Weight loss in Weight Watchers Online with and without an activity tracking device compared to control: a randomized trial. Extended and standard duration weight-loss programme referrals for adults in primary care (WRAP): a randomised controlled trial. Transtheoretical model–chronic disease care for obesity in primary care: a randomized trial. Study on lifestyle-intervention and impaired glucose tolerance Maastricht (SLIM): design and screening results. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). Effects of lifestyle intervention in persons at risk for type 2 diabetes mellitus—results from a randomised, controlled trial.

A dashed line indicates a relationship between an intermediate outcome and a health outcome that is presumed to describe the natural progression of the disease. adults who experienced substantial weight loss, 1999-2002. Long-term weight maintenance strategies are experienced as a burden by persons who have lost weight compared to persons with a lifetime normal, stable weight. Correlates of health-related quality of life, psychological well-being, and eating self-regulation after successful weight loss maintenance. What distinguishes weight loss maintainers of the German Weight Control Registry from the general population? Maintenance of weight loss or stability in subjects with obesity: a retrospective longitudinal analysis of a real-world population. Age and race impact the association between BMI and CVD mortality in women. Differences in cardiovascular disease mortality associated with body mass between black and white persons. Body mass index and cardiovascular disease in the Asia-Pacific Region: an overview of 33 cohorts involving 310 000 participants. Waist circumference thresholds provide an accurate and widely applicable method for the discrimination of diabetes. Ethnic differences in the relationships between obesity and glucose-metabolic abnormalities: a cross-sectional population-based study. Anthropometric cutoff points for predicting chronic diseases in the Mexican National Health Survey 2000. The effect of decision rules on the choice of a body mass index cutoff for obesity: examples from African American and white women. Variations in BMI and prevalence of health risks in diverse racial and ethnic populations. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Are Asians at greater mortality risks for being overweight than Caucasians?